 However the cost of developing, regulating and containing transgenic plants is high, leading to most current plant-based vaccine development being applied to veterinary medicine, where the controls are not as strict.The vast majority of genetically modified animals are at the research stage with the number close to entering the market remaining small.As of 2018 only three genetically modified animals have been approved, all in the USA.